Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.64)
# 2,009
Out of 5,124 analysts
305
Total ratings
57.34%
Success rate
-1.48%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $5 → $4 | $2.44 | +63.93% | 3 | Dec 18, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $11 → $6 | $4.44 | +35.14% | 6 | Dec 18, 2025 | |
| HCA HCA Healthcare | Downgrades: Underweight | $425 | $501.69 | -15.29% | 5 | Dec 15, 2025 | |
| ARDT Ardent Health | Downgrades: Equal-Weight | $22 → $12 | $8.94 | +34.23% | 3 | Nov 14, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $57 → $67 | $31.17 | +114.95% | 3 | Sep 23, 2025 | |
| VEEV Veeva Systems | Maintains: Underweight | $210 → $222 | $183.65 | +20.88% | 9 | Aug 28, 2025 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $157 → $144 | $206.50 | -30.27% | 15 | Aug 6, 2025 | |
| OMDA Omada Health | Initiates: Overweight | $25 | $11.65 | +114.59% | 1 | Jul 1, 2025 | |
| HIMS Hims & Hers Health | Reiterates: Equal-Weight | $40 | $23.02 | +73.76% | 4 | Jun 11, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $175 → $210 | $201.37 | +4.29% | 3 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $200 | $218.56 | -8.49% | 1 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $2.00 | +150.63% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $62.10 | +83.57% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $35.99 | +58.38% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $76.01 | +6.56% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $27.73 | +26.22% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $12.24 | +47.06% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $83.72 | +120.97% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $215.91 | -22.65% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $136.23 | -69.17% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $190.71 | -16.63% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $78.35 | +59.54% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $332.92 | -78.28% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $221.44 | -11.94% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $276.65 | +76.40% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $131.72 | +124.72% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $277.20 | +32.76% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $193.94 | +164.51% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $292.05 | -5.84% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $38.46 | +128.81% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $65.20 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $89.23 | +107.33% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $224.32 | -5.05% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $116.04 | -50.02% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $320.45 | -63.49% | 15 | Jun 16, 2020 |
GoodRx Holdings
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $2.44
Upside: +63.93%
American Well
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $11 → $6
Current: $4.44
Upside: +35.14%
HCA Healthcare
Dec 15, 2025
Downgrades: Underweight
Price Target: $425
Current: $501.69
Upside: -15.29%
Ardent Health
Nov 14, 2025
Downgrades: Equal-Weight
Price Target: $22 → $12
Current: $8.94
Upside: +34.23%
Hinge Health
Sep 23, 2025
Maintains: Overweight
Price Target: $57 → $67
Current: $31.17
Upside: +114.95%
Veeva Systems
Aug 28, 2025
Maintains: Underweight
Price Target: $210 → $222
Current: $183.65
Upside: +20.88%
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $144
Current: $206.50
Upside: -30.27%
Omada Health
Jul 1, 2025
Initiates: Overweight
Price Target: $25
Current: $11.65
Upside: +114.59%
Hims & Hers Health
Jun 11, 2025
Reiterates: Equal-Weight
Price Target: $40
Current: $23.02
Upside: +73.76%
Tenet Healthcare
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $201.37
Upside: +4.29%
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $218.56
Upside: -8.49%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $2.00
Upside: +150.63%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $62.10
Upside: +83.57%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $35.99
Upside: +58.38%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $76.01
Upside: +6.56%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $27.73
Upside: +26.22%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $12.24
Upside: +47.06%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $83.72
Upside: +120.97%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $215.91
Upside: -22.65%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $136.23
Upside: -69.17%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $190.71
Upside: -16.63%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $78.35
Upside: +59.54%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $332.92
Upside: -78.28%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $221.44
Upside: -11.94%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $276.65
Upside: +76.40%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $131.72
Upside: +124.72%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $277.20
Upside: +32.76%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $193.94
Upside: +164.51%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $292.05
Upside: -5.84%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $38.46
Upside: +128.81%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $65.20
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $89.23
Upside: +107.33%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $224.32
Upside: -5.05%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $116.04
Upside: -50.02%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $320.45
Upside: -63.49%